Data obtained in the third National Health and Nutrition Examination Survey (NHANES III), conducted during 1988-1994, were analyzed to determine the epidemiology of rubella seropositivity in the United States, including risk factors for low rubella seropositivity. Serological samples obtained from NHANES III study participants у6 years of age were tested for rubella IgG antibodies. "Rubella seropositivity" was defined as serum rubella IgG antibody level у10 IU by enzyme immunoassay. Overall, rubella seropositivity rates in the United States were 92% in persons aged 6-11 years, 83% in persons aged 12-19 years, 85% in persons aged 20-29 years, 89% in persons aged 30-39 years, and у93% in persons aged у40 years. The lowest rate (78%) of any United States birth cohort of the 20th century occurred among persons born from 1970-1974. Eliminating rubella and chronic rubella syndrome in the United States will require international efforts, including vaccination of preschool-and school-age children and all susceptible young adults.
1969, the number of reported rubella cases plummeted by 99%-from 56,552 cases in 1970, to 630 cases in 1985 [4, 5] and to an average of 183 cases per year in 1994-1996 [6] (figure 1). Although the number of states mandating rubella vaccination for school entry rose from 11 in 1970 to 34 in 1975 and then to all 50 states by 1979, such laws were not enforced immediately [7] . Rubella vaccination coverage rates for children aged 1-4 years rose from 37% in 1970 to just 59% in 1985 [8] . It was not until 1997 that 91% of children 19-35 months of age received a vaccine that included rubella [9] (figure 1).
The US Public Health Service has set a goal of eliminating indigenous rubella and CRS in the United States by the year 2010 [10] . Eliminating rubella in women of childbearing age is necessary to eliminate CRS, a preventable cause of birth defects. To determine the recent epidemiology of rubella immunity in the United States and to better target rubella immunization efforts, we analyzed rubella seropositivity data obtained in the third National Health and Nutrition Examination Survey (NHANES III), conducted during 1988-1994. 
METHODS
NHANES III is a cross-sectional national survey conducted by the National Center for Health Statistics of the Centers for Disease Control and Prevention (CDC) [11] to provide nationally representative statistics on a variety of health measures and conditions [11] . NHANES III was based on a complex, stratified, multistage, probability-cluster design from which a representative sample of the civilian, noninstitutionalized United States population was drawn. In NHANES III, children р5 years of age, persons у60 years of age, Mexican Americans, and non-Hispanic blacks were sampled at a higher rate than other persons. Participants or their parents or guardians were interviewed. Participants provided blood samples, which were tested without personal identifiers. Serum rubella IgG antibody titers were measured on surplus serum samples available for persons у6 years old.
Interview questions addressed the study participant's demographic characteristics, including age, race/ethnicity, sex, year and place of birth, place of residence, income, birthplace of participant's head of household, household crowding, the ability to identify a regular clinic or physician, United States military service, marital and employment history, and parity and gravidity for women. A history of rubella vaccination or disease was not obtained. For this analysis, race/ethnicity was defined by self-report as "non-Hispanic white," "non-Hispanic black," and "Mexican American." Persons who did not select one of these 3 groups were classified as "other" and analyzed only with the total population. Detailed descriptions of the sampling and survey design have been previously published [11] .
We received state-specific data on rubella vaccination requirements for school entry by year during the years 1970-1977 and 1979-1980 from the National Immunization Program, CDC. For persons aged 6-19 years, a variable was created designating whether rubella vaccination was required for school entry, under the assumption that the person entered school at 5 years of age in the same state in which he or she was born.
Laboratory methods. Serum samples were tested for rubella IgG antibody by indirect EIA (California State Department of Health Services, Viral and Rickettsial Disease Laboratory, Berkeley, CA) [12] . The absorbance of the rubella viral antigen (VA) well minus the absorbance of the uninfected cell as nonspecific (NS) control antigen well was used to calculate a VA Ϫ NS p rubella virus (RV) value. To determine the international unit (IU) value, a regression analysis was done and a standard curve was calculated using the RV values for the 10 IU, 40 IU, and 100 IU rubella standards and their squares. Positive rubella control standards consisted of World Health Organization or CDC standard 1000-IU serum samples, diluted to titers of 10, 40, and 100 IU. Rubella seropositivity for NHANES III was defined as a serum rubella IgG titer of у10 IU by EIA.
Statistical analysis. All estimates were weighted to represent the total United States population and to account for oversampling and nonresponse to the household interview and physical examination [13, 14] . Prevalence estimates and SEs were calculated with Survey Data Analysis (SUDAAN) for multistage sample designs [15] . Exact 95% CIs were calculated for the prevalence estimates by the method of Collett [16] . Univariate and multivariate analyses were stratified by age (subjects aged 6-19 years and 20-49 years) because several important predictor variables were applicable only to the adult population (e.g., marital status, occupation, education, military history, and pregnancy and childbirth history for women). We limited our adult analysis to those aged 20-49 years, because for persons aged у50 years, rubella seropositivity was stable at 190%. To screen for possible predictors of rubella seropositivity, differences in seroprevalence were evaluated without correction for multiple comparisons by means of a univariate t statistic from a general linear contrast procedure in SUDAAN. Variables demonstrating a univariate association with rubella seropositivity at were included in the multivariate analysis. Indepen-P ! .05 dent predictors were further determined by use of multivariate logistic regression. Variables with a Satterthwaite-adjusted F statistic with were considered significant [15] . Potential P ! .05 confounding effects of a variable on the remaining cofactors were evaluated on deletion from the model. No additional confounders were found.
Response rates. 12,493 non-Hispanic whites). Previous analysis of NHANES III data found no apparent bias from nonresponse [13] . Rubella seropositivity varied by birth cohort and age (figure 2). Seropositivity was highest (93.2%) for those born from 1901 through 1958, dropped to 87.5% for those born from 1959 through 1964, dropped further to 80.8% for those born from 1965 through 1977, and then rose to 91.4% for those born from 1978 through 1983. Differences in rubella seropositivity by birth cohort were all statistically significant ( ) except P ! .05 for the difference between the oldest and the youngest cohorts (1901-1958 vs. 1978-1983 ; figure 2). Within the birth cohort with the lowest rubella seropositivity, 1965-1977, a subgroup of persons had an even lower rubella seropositivity (78.8%); these persons were born during 1970-1974 and were 14-24 years of age during the NHANES III study.
RESULTS

Age
Among persons aged 6-19 years, higher rubella seropositivity was observed in those who were younger (6-11 years of age), were non-Hispanic black, had a metropolitan residence, lived in poverty, and had a non-United States birthplace for both the participant and the head of household (table 2) . The significance of these last 2 variables is primarily due to Mexican Americans, because the number of non-Hispanic whites and non-Hispanic blacks born outside the United States or with a head of household who was not born in the United States was quite small. Mexican Americans aged 6-19 years who were not born in the United States had higher seropositivity than did Mexican Americans who were born in the United States (91.2% vs. 83.6%;
). P ! .05 Multivariate logistic modeling among persons 6-19 years of age revealed that younger children (6-11 years of age) were more likely to be rubella-seropositive than were older children and adolescents (12) (13) (14) (15) (16) (17) (18) (19) ). P ! .05 For women aged 20-49 years, who were ever married, those who had given birth had higher rubella seropositivity than did those who had not, 714 (93.8%) versus 629 (81.3%;
). P ! .05 However, a history of 1 pregnancy that did not result in a live birth did not increase rubella seropositivity among women who were never married (82.5%; table 4). For women aged 20-49 years who were never married, rubella seropositivity did not vary by pregnancy history or parity.
For persons aged 20-49 years, multivariate logistic modeling showed that the likelihood of rubella seropositivity was higher among those aged 30-39 years, non-Hispanic blacks, those ever married, and those with a history of United States military service (table 5) . Those who could identify a regular clinic and health care provider had higher rubella seropositivity (OR, 1.29; 95% CI, 1.00-1.67; ), and those who ever worked in a P p .05 child care occupation had lower rubella seropositivity (OR, 0.61; 95% CI, 0.37-1.00;
; table 5). When examining P p .05 parity and gravidity among women aged 20-49 years, we found similar associations with age, non-Hispanic black race/ethnicity, child care occupation, and marital status. Pregnancy and birth history were not better predictors of seropositivity than was marital status and were eventually eliminated from the model.
Additional multivariate logistic modeling of rubella seropositivity among persons aged 20-49 years revealed a significant 
DISCUSSION
In our study, the lowest rate of rubella seropositivity in the United States occurred among persons born during 1965-1977, an age group who have already entered their years of childbearing-age. It is possible that waning vaccine-associated immunity was responsible for the decreased rubella seropositivity rates seen in this group of adolescents and young adults [17, 18] . However, the current RA 27/3 vaccine has been reported to provide persistent, long-term immunity [19] . It is more likely that the sharp drop in rubella incidence in the 1970s followed by the slow rise in rubella vaccination coverage from 1969 through 1998 (figure 1) resulted in a "lost generation" of young people who missed acquiring rubella antibodies because they were born too late to be exposed to circulating wild-type rubella during childhood but born too early to receive mandatory rubella vaccination at school entry. Consequently, the childbearing-age population in the United States contains a birth cohort (1970) (1971) (1972) (1973) (1974) with the lowest rubella seropositivity of any United States birth cohort in the 20th century (figure 2).
Our data indicate that although tremendous progress has been made in increasing rubella seropositivity in young children, particularly among non-Hispanic blacks and persons living in poverty, rubella susceptibility among adolescents and young adults remains a surprisingly large problem, especially for Mexican Americans born in the United States, women who were never married who have not delivered a child, and persons who are unable to identify a routine clinic or health care provider. Although the overall United States rubella herd immunity of 89.4% during 1988-1994 has successfully prevented national rubella epidemics, it has been unable to prevent occasional rubella outbreaks [20] [21] [22] or births of CRS-affected infants [5, 9] . Consequently, achieving elimination of rubella and CRS will require maintaining high rubella vaccination coverage of children and increasing rubella vaccination coverage of adults of childbearing-age. In addition, enforcement of state laws requiring a second dose of measles, mumps, rubella vaccine for schoolchildren, instituted in 1989 to protect those with primary measles vaccine failure, may also improve rubella seropositivity in adolescents. ). It may be that having a head of house-P ! .05 hold who was born outside the United States is a surrogate marker for increased exposure to rubella, possibly via visitors who import rubella into the United States or through increased travel outside the United States. Similarly, the significantly higher rubella seropositivity in non-Hispanic blacks aged 6-19 years and 20-49 years may indicate increased exposure to wildtype disease in this population as well [23] .
Adults aged 20-49 years with a history of medical or military occupations had significantly higher rubella seropositivity than did those who did not, indicating the benefit of employer- provided and/or employer-mandated rubella immunization. Persons aged 20-49 years who had ever worked in child care had lower rubella seropositivity, a troubling association because children with rubella or CRS can easily transmit the virus to pregnant caretakers who are susceptible to rubella. However, only a relatively small number of child care workers were identified in this subgroup; therefore, the sample size may not be adequate to describe this population.
One limitation of this study is the lack of sufficient data to estimate seroprevalence for other minority groups beyond nonHispanic blacks and Mexican Americans. Also, the study did not include participants from United States territories, possessions, or commonwealths, although residents of these areas are United States citizens and eligible to move anywhere within the United States. Because no information on rubella vaccination was collected, the effect of rubella vaccination on rubella seropositivity could not be determined. Specific information on access to immunization services was not collected; only surrogate variables on whether the person could name a clinic and/or health care provider were available.
Hinman et al. [24] noted in 1983 that the weakest part of the United States rubella vaccination strategy was immunizing those currently at risk of having a pregnancy complicated by rubella (e.g., women of childbearing age). This remains true today. Premarital rubella immunization of women may have raised rubella seropositivity in women of childbearing age because the rubella seropositivity in married women aged 20-49 years did not vary significantly by pregnancy or childbirth history. However, premarital immunization policies have probably become less effective in vaccinating women before childbearing because an increasing number of births in the United States are to unmarried women [25] . In 1997, 32% of all infants in the United States, 22% of non-Hispanic white infants, 69% of non-Hispanic black infants, and 39% of Mexican American infants were born to unmarried women [25] .
For women aged 20-49 years who were never married, rubella seropositivity did not rise significantly after 1 pregnancy but rose only after a live birth. Although this suggests that many reproductive health care providers follow guidelines for postpartum rubella immunization [26, 27] , the delay in immunizing some women of childbearing age means that current vaccination practices will not always protect firstborn or even secondborn children from CRS, especially when the mother is unmarried. This is supported by CRS surveillance data acquired during 1985-1996, which show that 46 (52%) of 87 mothers of infants with indigenously acquired CRS had at least 1 previous live birth [28] . Therefore, rubella immunization programs should seek out and immunize rubella-susceptible adolescents and adult women before their first pregnancy, regardless of marital status or stated intention to delay childbearing.
Several barriers still remain to improving rubella vaccination coverage in persons of childbearing age. A major barrier in the United States is limited access to preventive health care by rubella-susceptible populations [29, 30] . Because rubella vaccination is not mandated and provided for adults as it is for children (at school entry), targeted and more complicated strategies are needed to ensure that adults of childbearing age are rubella-immune. Also, some health insurance policies may not pay for adult vaccinations [31] . A fourth barrier to adult immunization is concern about possible adverse events. Although one center reported a possible association between chronic arthropathy and rubella vaccination in women [32, 33] , recent studies by others have not replicated these findings [34] [35] [36] [37] . A fifth barrier is the ignorance of many adults, including some physicians, of the importance of adult immunizations [38, 39] . Indeed, physicians may lack adequate training in vaccine-preventable diseases [39] . Therefore, formal immunization training regarding the importance of immunizing both pediatric and adult patients should be incorporated into all primary care residency training and continuing medical education programs [39] .
Clinicians should use every opportunity to vaccinate adolescents and young adults who lack documentation of rubella immunity [27] . Eliminating rubella and CRS in the United States will not occur until national rubella vaccination programs are expanded to include rubella vaccination coverage for women of childbearing age [21] , especially unmarried women and those born during 1965-1977. As with other vaccine-preventable diseases, such as measles and polio, close collaboration with other countries to intensify rubella immunization efforts will be necessary to entirely eliminate rubella [5, 40] .
